CDKN2A mutations in Scottish families with cutaneous melanoma: results from 32 newly identified families
- 1 December 2005
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 153 (6) , 1121-1125
- https://doi.org/10.1111/j.1365-2133.2005.06846.x
Abstract
Up to 5% of patients with melanoma have a family history of a first-degree relative also being affected. To study such families for germline mutations, to help clarify the gene-environment interaction in melanoma aetiology. Thirty-two families in Scotland with melanoma in two or more first-degree relatives are reported for the first time. Peripheral blood DNA was extracted, and denaturing high-performance liquid chromatography analysis performed on exons 1alpha and 2 of the CDKN2A gene and their splice junctions. The coding sequences and splice junctions of these exons were sequenced in all samples as confirmation of the chromatographic pattern observed. Seven of the 32 melanoma families (22%) have CDKN2A mutations. One mutation, H83N, which has not previously been described in melanoma families, was found in one family. In addition, two families have R112G mutations, one family has a G67R mutation, one has an exon 1alpha 24-bp duplication where bases 9-32 are duplicated between bases 32 and 33, and two families have M53I mutations, bringing the total of known Scottish families with the M53I mutation to six. This study brings the total of Scottish families investigated for germline mutations to 48, and strongly suggests that the M53I mutation originated in Scotland.Keywords
This publication has 26 references indexed in Scilit:
- An Assessment of the CDKN2A Variant Ala148Thr as a Nevus/Melanoma Susceptibility AlleleJournal of Investigative Dermatology, 2002
- Geographical Variation in the Penetrance of CDKN2A Mutations for MelanomaJNCI Journal of the National Cancer Institute, 2002
- Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma familiesEuropean Journal of Human Genetics, 2000
- Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Human Molecular Genetics, 1998
- Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindredsOncogene, 1997
- Germline mutations in the p16INK4a binding domain of CDK4 in familial melanomaNature Genetics, 1996
- Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4MutationsNew England Journal of Medicine, 1995
- A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor GeneNew England Journal of Medicine, 1995
- Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindredsHuman Molecular Genetics, 1995
- Germline p16 mutations in familial melanomaNature Genetics, 1994